Crispr Therapeutics shares owned by Rokos Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Rokos Capital Management
from 13F filings
Historical chart of Rokos Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Rokos Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Rokos Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $4.1M | 88k | 46.57 |
| 2023-06-30 | $4.9M | 88k | 55.98 |
| 2023-03-31 | $3.9M | 88k | 45.13 |
| 2022-12-31 | $3.5M | 88k | 39.83 |
| 2022-09-30 | $5.9M | 88k | 67.06 |
| 2022-06-30 | $5.5M | 88k | 62.85 |
| 2022-03-31 | $5.6M | 88k | 64.16 |